InvestorsHub Logo
Followers 17
Posts 28
Boards Moderated 0
Alias Born 11/20/2014

Re: None

Tuesday, 12/23/2014 9:05:23 PM

Tuesday, December 23, 2014 9:05:23 PM

Post# of 60694
Update

A few things of interest:

1) CB - should hear back from them within the next few days and would be quite surprised if it's >$5k left. I'm still needing it to be $0 before any type of firm proposal is made to a target acquisition as per the previous PR.

2) speaking of the previous PR, I did a bit of research which frankly, was quite enlightening - I spoke with the management of the previous three LOI's that the company signed - iMedia, IRIS and the people at UCSF.

Apparently, the first one with iMedia years back was negated due to iMedia obtaining a $10 million investment from IDG and subsequently another $20 million from Kleiner Perkins. They'll probably be on the IPO path fairly soon so no surprise there.

IRIS - that was due to two factors: one, fairly aggressive demands on structure by IRIS' owners for equity stake. They wanted 99% of the post-transaction capital structure. two, they had a fairly sizable debt load which would have shifted to the public company as well.

UCSF - they went with another group as the outstanding CB was at the time, still pretty sizable (approximately > $100k). This created an unknown variable in terms of ability to stabilize price for proper growth funding and as evidenced by the decimated share price from the CB conversions, a smart choice for the stem cell delivery device IP owners and investors as well as UCSF.

Another overriding factor, with both IRIS and UCSF, was the lack of synergy with STOA's current business of e-commerce software and the need to completely change the underlying business. This can be readily done although better suited to a public company that is in the same line of business.

>>>>>>

I'm hoping that either rebuilding the current business into more profitable areas or finding the best acquisition target that has synergy can create some value. This will have to be tempered with the needs of both current investors as well as an incoming target company's management preference on share price/shares issued and outstanding.

Hope this helps and doesn't get attacked for grammatical errors as a sign of fraud smile

Happy Holidays to all.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent LGIQ News